Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)
China
· Delayed Price · Currency is CNY 28.76
+0.12 (0.42%)
Apr 30, 2026, 9:55 AM CST
Shandong Wit Dyne Health Revenue
Shandong Wit Dyne Health had revenue of 412.27M CNY in the quarter ending March 31, 2026, a decrease of -33.10%. This brings the company's revenue in the last twelve months to 2.02B, down -7.10% year-over-year. In the year 2025, Shandong Wit Dyne Health had annual revenue of 2.23B with 4.40% growth.
Revenue (ttm)
2.02B
Revenue Growth
-7.10%
P/S Ratio
3.32
Revenue / Employee
1.15M
Employees
1,759
Market Cap
6.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.23B | 93.89M | 4.40% |
| Dec 31, 2024 | 2.13B | -349.67M | -14.08% |
| Dec 31, 2023 | 2.48B | 143.09M | 6.11% |
| Dec 31, 2022 | 2.34B | 313.93M | 15.49% |
| Jan 1, 2022 | 2.03B | 206.11M | 11.32% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tianjin Tianyao Pharmaceuticals | 2.73B |
| Hainan Haiyao | 792.76M |
| Tibet Duo Rui Pharmaceutical | 154.18M |
| Cisen Pharmaceutical | 3.44B |
| Beijing Sun-Novo Pharmaceutical Research | 1.19B |
| Hunan Jiudian Pharmaceutical | 3.01B |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 1.42B |
| Guizhou Bailing Group Pharmaceutical | 2.93B |